Guardant Health
GH
#1349
Rank
HK$130.46 B
Marketcap
HK$983.89
Share price
-5.60%
Change (1 day)
160.89%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2025

Annual Report 2025

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2023

Annual Report 2023

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report